Courage Capital Management’s Evolent Health EVH Stock Holding History

Courage Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,410	Closed	-$1.18M	–	24
2022 Q1	$1.18M	Sell	36,410 -258,748	-88%	-$6.77M	1.12%	19
2021 Q4	$8.17M	Sell	295,158 -4,842	-2%	-$139K	5.39%	4
2021 Q3	$9.3M	Sell	300,000 -200,000	-40%	-$4.8M	4.98%	5
2021 Q2	$10.6M	Buy	500,000 +131,909	+36%	+$2.64M	6.31%	4
2021 Q1	$7.43M	Hold	368,091	–	–	5.43%	7
2020 Q4	$5.9M	Sell	368,091 -31,909	-8%	-$422K	5.88%	6
2020 Q3	$4.96M	Buy	400,000 +200,000	+100%	+$2.35M	5.54%	5
2020 Q2	$1.42M	Buy	+200,000	New	+$1.34M	2.62%	12

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Courage Capital Management's EVH Position: Q2 2022 in Review

Courage Capital Management sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 36,410 shares — an estimated $1.18M sold.

Courage Capital Management first reported a position in EVH in Q2 2020 and held it in 8 quarters. The position peaked at $10.6M in Q2 2021. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

Courage Capital Management reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
Courage Capital Management sold 36,410 Evolent Health shares in Q2 2022, an estimated $1.18M.
Courage Capital Management first reported a position in Evolent Health in Q2 2020 and held it in 8 quarters.
Courage Capital Management's Evolent Health position peaked at $10.6M in Q2 2021.
215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Courage Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.